3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
2
Recruiting
1
Not yet recruiting
1
Completed
1
Approved for marketing
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, B-Cell
2
Waldenstrom Macroglobulinemia
1
Recurrence
1
Lymphoma, Mantle-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Interventions
zanubrutinib
3
Rituximab
3
Bendamustine Hydrochloride
3
ibrutinib
2
talquetamab
1
pirtobrutinib
1
Sra protein, Drosophila
1
Specimen Handling
1
Sirolimus
1
Prednisone
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Everolimus
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Waldenstrom Macroglobulinemia
×
pirtobrutinib
×
Clear all
NCT07548450
2026-04-23
MPOWER
University of Utah
Phase 2
Not yet recruiting
25 enrolled